201 related articles for article (PubMed ID: 38222576)
1. In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles.
Rastegari B; Ghamar Talepoor A; Khosropanah S; Doroudchi M
ACS Omega; 2024 Jan; 9(1):658-674. PubMed ID: 38222576
[TBL] [Abstract][Full Text] [Related]
2. Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.
Kühnast S; Louwe MC; Heemskerk MM; Pieterman EJ; van Klinken JB; van den Berg SA; Smit JW; Havekes LM; Rensen PC; van der Hoorn JW; Princen HM; Jukema JW
PLoS One; 2013; 8(6):e66467. PubMed ID: 23840481
[TBL] [Abstract][Full Text] [Related]
3. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
[TBL] [Abstract][Full Text] [Related]
4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).
Zhao XQ; Morse JS; Dowdy AA; Heise N; DeAngelis D; Frohlich J; Chait A; Albers JJ; Brown BG
Am J Cardiol; 2004 Feb; 93(3):307-12. PubMed ID: 14759379
[TBL] [Abstract][Full Text] [Related]
6. Safety of niacin and simvastatin combination therapy.
Bays H
Am J Cardiol; 2008 Apr; 101(8A):3B-8B. PubMed ID: 18375239
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
Brown BG; Zhao XQ; Chait A; Fisher LD; Cheung MC; Morse JS; Dowdy AA; Marino EK; Bolson EL; Alaupovic P; Frohlich J; Albers JJ
N Engl J Med; 2001 Nov; 345(22):1583-92. PubMed ID: 11757504
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial.
Stein EA; Davidson MH; Dujovne CA; Hunninghake DB; Goldberg RB; Illingworth DR; Knopp RH; Miller VT; Frost P; Isaacsohn JL; Mitchel YB; Melino MR; Shapiro D; Tobert JA
J Cardiovasc Pharmacol Ther; 1996 Apr; 1(2):107-116. PubMed ID: 10684407
[TBL] [Abstract][Full Text] [Related]
9. Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy.
Airan-Javia SL; Wolf RL; Wolfe ML; Tadesse M; Mohler E; Reilly MP
Am Heart J; 2009 Apr; 157(4):687.e1-8. PubMed ID: 19332196
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
Karas RH; Kashyap ML; Knopp RH; Keller LH; Bajorunas DR; Davidson MH
Am J Cardiovasc Drugs; 2008; 8(2):69-81. PubMed ID: 18422390
[TBL] [Abstract][Full Text] [Related]
11. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan.
Lin TH; Voon WC; Yen HW; Huang CH; Su HM; Lai WT; Sheu SH
Kaohsiung J Med Sci; 2006 Jun; 22(6):257-65. PubMed ID: 16793562
[TBL] [Abstract][Full Text] [Related]
13. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro evaluation of niacin-loaded nanoparticles to reduce prostaglandin mediated vasodilatory flushing.
Cooper DL; Carmical JA; Panus PC; Harirforoosh S
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3977-88. PubMed ID: 26531288
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan derived nanoparticle for simvastatin delivery: evaluation of simvastatin induced myotoxicity in tissue engineered skeletal muscle.
Jones JM; Player DJ; Samanta S; Rangasami VK; Hilborn J; Lewis MP; Oommen OP; Mudera V
Biomater Sci; 2019 Dec; 8(1):302-312. PubMed ID: 31701967
[TBL] [Abstract][Full Text] [Related]
16. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs.
Imanparast F; Faramarzi MA; Vatannejad A; Paknejad M; Deiham B; Kobarfard F; Amani A; Doosti M
Microvasc Res; 2017 Jul; 112():14-19. PubMed ID: 28161429
[TBL] [Abstract][Full Text] [Related]
17. A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin.
Yiu KH; Cheung BM; Tse HF
Expert Opin Investig Drugs; 2010 Mar; 19(3):437-49. PubMed ID: 20141348
[TBL] [Abstract][Full Text] [Related]
18. Change in alpha1 HDL concentration predicts progression in coronary artery stenosis.
Asztalos BF; Batista M; Horvath KV; Cox CE; Dallal GE; Morse JS; Brown GB; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):847-52. PubMed ID: 12637338
[TBL] [Abstract][Full Text] [Related]
19. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy.
Chen Q; Gao M; Li Z; Xiao Y; Bai X; Boakye-Yiadom KO; Xu X; Zhang XQ
J Control Release; 2020 Jul; 323():179-190. PubMed ID: 32334322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
